Proud to work for an organization that continues to grow without sacrificing quality science or customer service!

#CASESTUDY: When a complex #ADA #assay failed at two prior #CROs, the sponsor turned to BioAgilytix for help. See how our European team applied a novel approach to overcome target interference challenges on a tight deadline: bit.ly/2X1pukL

What disease causes chronic, progressive, inflammatory musculoskeletal symptoms that can impact daily life? #AnkylosingSpondylitis. bit.ly/2EHfsPu

In need of biomarker support? Check out our #biomarker menu and schedule a time to discuss with one of our experts today! bit.ly/2EGkGLF It's just been updated!!

Dr. Arno Kromminga, Chief Scientific Advisor and co-founder of Bioagilytix’s European Headquarters, led that team’s involvement in some of the first cases of #immunogenicity. bit.ly/2RB8kaV He's participating in the #EBFAutumnFocusWorkshop this week!

BioAgilytix Labs is excited to welcome Kennon Broadhurst to the team, bringing with him over 26 years of experience in sales, marketing, and product commercialization experience within the Pharmaceutical and Biotech industries. prn.to/3iVLSoD

BioAgilytix is #hiring! Our lab in Boston is looking for experienced #PrincipalInvestigators to join our team. Click here to apply now➡️ bit.ly/2FPRVwH #BioAgilytixCareers #BostonCareers

Next month, several members of the BioAgilytix family will be presenting at the AAPS for the 2020 PharmSci 360. Including Luke Armstrong, who will be presenting on Validated Assay for Neutralizing Antibodies Against AAV9 in Human Serum. Register today: bit.ly/3iGUtf5

After you cast your vote on November 3rd, tune in to hear BioAgilytix's Anita Simkins, VP of Global QA. She will be presenting on bioanalytical labs during a pandemic. Register for her event here: cdmcd.co/zxGj7r #PharmSci360 #QA #QualityAssurance

Looking forward to the next few weeks of presentations and networking. Who else is planning to attend? #PharmSci360

Round TWO starting soon!! If you missed Jim McNally’s presentation earlier, don’t worry. You can still register for the next one!⬇️⬇️

It’s an honor to have a front row seat for Hendrik Neubert’s presentation!

BioAgilytix was born in NC and we're fortunate to call it home. We’re proud of the growth we've had over the last 12 years. It’s enabled us to invest in science, expand & create more local jobs. We look forward to continued prosperity in this great state. bit.ly/3kGDMRQ

At BioAgilytix Europe, our passion for the science of large molecule #bioanalysis drives our ability to deliver premium, tailored services for biomarker, immunogenicity, pharmacokinetics (PK), and cell-based assays. Learn more >> bit.ly/37RJpca <<

Big thanks to Jim McNally for being my first guest on Molecular Moments! We had a great conversation about the future of gene therapy and his personal connections to the field. Can’t wait to have him back in a future episode!

How does the globalization of regulations impact pharmaceutical development in the future? Chad Briscoe and his guest, Ph.D. scientist, Jim McNally discuss the impacts. Listen here: bit.ly/3oku9dF

At this year's National Biotechnology Conference put on by American Association of Pharmaceutical Scientists, Chad Briscoe from BioAgilytix will be hosting a live panel discussion with a few poster authors! Register for the virtual conference & learn from our thought leaders May 17-20, 2021: bit.ly/3eVmgaJ

Are you attending this year's National Biotechnology Conference put on by American Association of Pharmaceutical Scientists? Chad Briscoe from BioAgilytix will be hosting a live panel discussion with a few poster authors. Register & learn from our thought leaders May 17-20, 2021: bit.ly/3eVmgaJ

Attending the American Association of Pharmaceutical Scientists NBC conference? Virtually join others working in the highly specialized space of cell & gene therapy programs & share your experiences! Jim McNally will moderate a session TODAY at 9 AM EST. Learn more here: bit.ly/3vLRnwc

Just like we drew it up.